BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 8, 2015
View Archived Issues
Transformed porcine mammary epithelial cells form xenograft tumors in mice
Read More
MAF is a biomarker of breast cancer bone metastasis
Read More
MedImmune initiates phase I study of MEDI-9197 for solid tumor cancers
Read More
PTP1B shows promise for the improvement of islet graft revascularization
Read More
Daiichi Sankyo divulges EZH1/EZH2 inhibitors
Read More
MyoKardia provides update on two phase I trials of MYK-461
Read More
Osiris begins phase III trial of OTI-15-01 in chronic diabetic foot wounds
Read More
Abeona Therapeutics forms license agreement for next-generation AAV delivery vector
Read More
Serendex reports results from phase I trial of inhaled GM-CSF
Read More
GreenPeptide files IND for cancer peptide vaccine GRN-1201
Read More
FDA grants priority review to Daklinza supplemental NDAs
Read More
Avelumab receives FDA fast track designation for metastatic Merkel cell carcinoma
Read More
Novel insulin mutation linked to autosomal dominant diabetes
Read More
Nektar submits IND for NKTR-214 to treat solid tumor malignancies
Read More
Paranta Biosciences starts phase I trial of inhaled follistatin
Read More
Bristol-Myers Squibb introduces NS5B inhibitors
Read More
Capella Therapeutics patents EGFR inhibitors
Read More
Bayer Schering Pharma divulges Wnt signaling inhibitors
Read More
Agios presents glutaminase inhibitors
Read More
MD Anderson and Theraclone partner to launch new company OncoResponse
Read More
DeNovo Sciences and bioTheranostics to collaborate on detection of cancer biomarkers in blood
Read More
Octapharma acquires license to Glycotope's recombinant technology, takes shareholding
Read More
FDA grants rare pediatric disease designation to deflazacort for DMD
Read More
Nivalis announces topline results from phase Ib study of N-91115 in cystic fibrosis
Read More
RATHER collaboration reports on phase II trial of taselisib in hard-to-treat breast cancers
Read More